Australia's Sigma on halt, plans announcement
SYDNEY, April 12 (Reuters) - Australian drugs firm Sigma Pharmaceuticals Ltd. (SIP.AX) requested its shares be placed on a trading halt on Thursday ahead of an announcement.
"A trading halt is necessary as Sigma expects to make an announcement in relation to a significant development," the company said in a statement.
Australian healthcare companies are in a flurry of takeover activity and speculation, and Sigma has said previously it was in the market for future acquisitions.
((Reporting by Richard Pullin; richard.pullin@reuters.com; Reuters Messaging: richard.pullin.reuters.com@reuters.net; +612 9373 1816)) Keywords: SIGMA/
(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nSYU002142









